Centric Health Resources in St. Louis, Mo., serves patients who have the rarest diseases and need the most expensive drugs.
Pharmacists can interact directly and personally with patients only during counseling. This practice reduces the risk of mechanical prescription errors and shows patients what the pharmacist's education and training were all about.
Pharmacists who are motivated to educate themselves about the treatment of chronic pain can relieve suffering and improve lives.
The Caverject Impulse Dual Chamber System, a drug delivery device used to treat erectile dysfunction that was withdrawn by the manufacturer, will return to pharmacy shelves, according to Pfizer, Inc.
DEA wants to make it easier for hospitals, long-term-care facilities, patients, and others to dispose of controlled substances. FDA, EPA, and state agencies are also dealing with this issue.
The slumping U.S economy and government regulations will cause pharmacy sales to grow only around 1.3 percent rate in 2009, according to new research presented last week at the American Society for Automation in Pharmacy?s Industry and Technology Issues in St. Petersburg, Fla.
When dealing with Clostridium difficile infections in the healthcare setting, "if we don't do the right thing, patients die," said Rob Owens, PharmD, co-director of the Antimicrobial Stewardship Program at Maine Medical Center and assistant clinical professor at the University of Vermont, College of Medicine, at a talk on the diagnosis and treatment of C difficile.
Medicare Survival Kit Links
New over the counter items with unique formulations
Pharmacy industry critics are "gravely concerned" that the Safe Drug Compounding Act of 2007, a draft Senate bill, would sharply curtail the practice of compounding by giving the Food & Drug Administration authority to regulate compounding. A coalition of nine pharmacy organizations drafted a letter to the bill's expected sponsors—Senators Edward Kennedy (D, Mass.), Pat Roberts (R, Kan.), and Richard Burr (R, N.C.)—insisting that the bill "would negatively impact patient access to necessary compounded prescription medications and create onerous, new requirements for prescribers and pharmacists."